InvestorsObserver
×
News Home

Can Verve Therapeutics Inc (VERV) Stock Rise to the Top of Healthcare Sector Tuesday?

Tuesday, March 26, 2024 11:47 AM | InvestorsObserver Analysts

Mentioned in this article

Can Verve Therapeutics Inc (VERV) Stock Rise to the Top of Healthcare Sector Tuesday?

A rating of 75 puts Verve Therapeutics Inc (VERV) near the top of the Healthcare sector according to InvestorsObserver. Verve Therapeutics Inc's score of 75 means that it ranks higher than 75% of stocks in the sector. In addition, its overall score of 47 ranks it higher than 47% of all stocks.

Overall Score - 47
VERV has an Overall Score of 47. Find out what this means to you and get the rest of the rankings on VERV!

What do These Ratings Mean?

Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. *Investors Observer* makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts. Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Verve Therapeutics Inc Stock Today?

Verve Therapeutics Inc (VERV) stock has fallen -1.6% while the S&P 500 has gained 0.25% as of 11:46 AM on Tuesday, Mar 26. VERV is down -$0.21 from the previous closing price of $13.16 on volume of 172,798 shares. Over the past year the S&P 500 has gained 31.53% while VERV is down -11.72%. VERV lost -$3.12 per share the over the last 12 months. Click Here to get the full Stock Report for Verve Therapeutics Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App